Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01719055 · ClinicalTrials.gov registry record
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
A clinical trial of Pain, sponsored by Boston Scientific Corporation.
- Recruiting
- Registry status
- 4,800
- Enrollment target
- 20
- Study locations
NCT01719055: Recruiting study of Pain, sponsored by Boston Scientific Corporation.
NCT01719055 is a study of Pain that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 4,800 participants, above the 291-participant average among 374 other Pain trials with a reported enrollment target (1549% higher). The trial reports 20 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01719055, a study of Pain, is actively recruiting participants, sponsored by Boston Scientific Corporation.
- RECRUITING
- Registry status
- 4,800 participants
- Enrollment target
- 20
- Study locations
Study Summary
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use \- and - To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice
Conditions Studied
Interventions
- DEVICE neurostimulation system
Study Locations (20)
Florida
- Orlando Health Neuroscience Institute, Inc - Clermont
- South Lake Pain Institute, Inc - Clermont
- University of Florida Shands Hospital - Gainesville
- Louis J. Raso, MD, PA - Jupiter
- Advanced Interventional Pain Management and Research Clinic, Inc. - Miami Gardens
- JM Clinical Research - South Miami
- Tallahassee Neurological Clinic, PA - Tallahassee
California
- Comprehensive Pain Management Center - Campbell
- Coastal Research Institute - Carlsbad
- Pain Medicine Associates, Inc. - Fountain Valley
- Metropolitan Pain Management Consultants Inc. - Sacramento
- Huntley Pain Specialists - San Diego
- Conejo Pain Specialists - Thousand Oaks
Arizona
- Physicians Research Group, LLC - Phoenix
- Hope Research Institute - Phoenix
- Banner University Medical Center - Tucson
Georgia
- Orthopedic Research Foundation - Savannah
- Pain Care, LLC - Stockbridge
Colorado
- Denver Back Pain Specialists - Greenwood Village
Illinois
- Northwestern Memorial Hospital - Neurosurgery Outpatient Clinic - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,800 participants |
| Start Date | 2012-11-19 |
| Est. Completion | 2035-05 |
What NCT01719055 shows while recruiting
NCT01719055 is an observational study that tracks outcomes without assigning an intervention. Its 4,800 participants enrollment target places it among the larger protocols in the corpus, above the 291-participant average among 374 other Pain trials with a reported enrollment target (1549% higher).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which neurostimulation system is the first listed.
NCT01719055 names 20 study sites across 6 states, led by Florida, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT01719055 about?
NCT01719055 is a clinical study titled "RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain". To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use \- and - To evaluate the economic value and technical performance of Bos...
What is the current status of trial NCT01719055?
This trial is currently recruiting. The enrollment target is 4,800 participants. The study started on 2012-11-19. Estimated completion is 2035-05.
What conditions does trial NCT01719055 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT01719055?
The interventions under investigation include: neurostimulation system (DEVICE).
Who is sponsoring clinical trial NCT01719055?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01719055 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01719055's enrollment target sits among peer trials
4,800 5th of 374 higher than 370 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
- NCT06307652 · 4,800 participants · Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
- NCT05929976 · 4,900 participants
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI